Boston Bio Systems Ltd

Boston Commerce Ltd has announced a Board of Directors meeting scheduled for July 7, 2026. The agenda includes considering a promoter's reclassification request, approving fund-raising of up to ₹100 Crores annually through inter-corporate loans, borrowings, advances, or equity issuances until FY2028-29. The board will also discuss related party transactions, potential acquisitions, appointment of auditors, shifting the registered office, and a proposed capital reduction scheme.

Boston Commerce Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is effective from July 1, 2026, and will continue until 48 hours after the declaration of the Unaudited Standalone Financial Results for the quarter ending June 30, 2026. The decision aligns with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. Insiders, designated persons, and their immediate relatives are advised against trading in the company's shares during this period. The date for the board meeting to approve these financial results will be communicated separately.

Boston Commerce Ltd has released revised financial results for the year ended March 31, 2026. The company reported a net loss of ₹724.17 lakhs for the quarter and ₹717.61 lakhs for the year. This revision follows a query regarding its Large Corporate Entity status. The audited standalone financial results were prepared in accordance with Indian Accounting Standards (Ind AS). The company's statutory auditors, M/s Sunit M Chhatbar & Co., issued a modified/qualified opinion on the financial statements, with a Statement of Impact of Audit Qualifications also enclosed. The company operates as a single reportable segment.

Boston Commerce Ltd has revised its financial results for the quarter and year ended March 31, 2026. The company cited a clerical error in its previous announcement, where an unmodified opinion was mistakenly enclosed. The Statutory Auditors, M/s Sunit M Chhatbar & Co., have issued a modified/qualified opinion. The revised filing includes the Audited Standalone Financial Results along with the Statement of Impact of Audit Qualifications. The company reported a net loss of ₹724.11 lakhs for the quarter and ₹717.61 lakhs for the year ended March 31, 2026.

Boston Commerce Ltd announced that its Board of Directors has approved the initiation of a process to formulate a Scheme for confirmation and write-off of certain not readily realizable assets. This process is subject to shareholder and regulatory approvals. The Board also approved the initiation of a Scheme of Capital Reduction, which will be presented to shareholders for approval at an upcoming Extraordinary General Meeting. Management has been authorized to proceed with the necessary actions for these initiatives.

Boston Commerce Ltd has scheduled a meeting of its Board of Directors on June 5, 2026, to consider and approve a proposal for the reduction of the company's share capital, subject to required approvals under the Companies Act, 2013, and other applicable laws. The board will also address any other matter with the chair's permission.

Boston Commerce Ltd's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026. The audit report, with an unmodified opinion, was submitted in compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Auditors SUNIT M CHHATBAR & CO have expressed a true and fair view of the net loss and other financial information for the quarter and year.

Boston Commerce Ltd's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, as recommended by the Audit Committee. The results, along with the auditor's report with an unmodified opinion, were reviewed in a board meeting held on May 30, 2026. The auditor's report stated that the financial results give a true and fair view of the net loss and other financial information for the quarter and year ended March 31, 2026.

Boston Commerce Ltd has scheduled a meeting of its Board of Directors on May 30, 2026, to consider and approve the audited standalone financial results for the quarter and year ended March 31, 2026. The trading window for the company's equity shares, which was closed from April 1, 2026, will reopen 48 hours after the results are declared and made public following the board meeting.

The Board of Directors of Boston Commerce Ltd, in its meeting held on May 12, 2026, approved the resignation of Independent Directors Mr. Aashish Shrirang Dharmadhikari and Ms. Swati Suresh Dhadve, effective the same date. The board also approved the appointment of Ms. Jansi Patel and Ms. Gunjan Jyotishbhai Leuva as Additional Directors in the category of Independent Director for a term of five years, subject to member approval. The Board also re-constituted its committees.